FI113741B - Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi - Google Patents
Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi Download PDFInfo
- Publication number
- FI113741B FI113741B FI992360A FI19992360A FI113741B FI 113741 B FI113741 B FI 113741B FI 992360 A FI992360 A FI 992360A FI 19992360 A FI19992360 A FI 19992360A FI 113741 B FI113741 B FI 113741B
- Authority
- FI
- Finland
- Prior art keywords
- product
- milk
- fermentation
- casein
- peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 56
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 38
- 230000003276 anti-hypertensive effect Effects 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims description 36
- 230000008569 process Effects 0.000 title claims description 22
- 238000002360 preparation method Methods 0.000 title claims description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000005018 casein Substances 0.000 claims abstract description 26
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000021240 caseins Nutrition 0.000 claims abstract description 24
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 17
- 239000004310 lactic acid Substances 0.000 claims abstract description 17
- 241000894006 Bacteria Species 0.000 claims abstract description 13
- 239000007858 starting material Substances 0.000 claims abstract description 10
- 238000000855 fermentation Methods 0.000 claims description 35
- 230000004151 fermentation Effects 0.000 claims description 35
- 238000001728 nano-filtration Methods 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 20
- 210000004080 milk Anatomy 0.000 claims description 19
- 235000013336 milk Nutrition 0.000 claims description 18
- 239000008267 milk Substances 0.000 claims description 18
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 14
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 11
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 6
- 102000014171 Milk Proteins Human genes 0.000 claims description 4
- 108010011756 Milk Proteins Proteins 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 235000021239 milk protein Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 4
- 239000000654 additive Substances 0.000 abstract description 2
- 230000000996 additive effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 80
- 239000005862 Whey Substances 0.000 description 16
- 102000007544 Whey Proteins Human genes 0.000 description 16
- 108010046377 Whey Proteins Proteins 0.000 description 16
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 16
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 15
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 15
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 14
- 230000036772 blood pressure Effects 0.000 description 13
- 206010020772 Hypertension Diseases 0.000 description 10
- 239000012528 membrane Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 235000020183 skimmed milk Nutrition 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 239000005541 ACE inhibitor Substances 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 6
- 235000021262 sour milk Nutrition 0.000 description 6
- 239000011575 calcium Substances 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 229940030600 antihypertensive agent Drugs 0.000 description 4
- 239000002220 antihypertensive agent Substances 0.000 description 4
- 235000015155 buttermilk Nutrition 0.000 description 4
- 230000001631 hypertensive effect Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- -1 Bristol-Myers Squibb Chemical compound 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 101710089384 Extracellular protease Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 108010007859 Lisinopril Proteins 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000020167 acidified milk Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229960000830 captopril Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000021001 fermented dairy product Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 229960002394 lisinopril Drugs 0.000 description 2
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- DAOGFHQPAHSMQS-LURJTMIESA-N (2s)-1-propanoylpyrrolidine-2-carboxylic acid Chemical compound CCC(=O)N1CCC[C@H]1C(O)=O DAOGFHQPAHSMQS-LURJTMIESA-N 0.000 description 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- 101800000734 Angiotensin-1 Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000917016 Lactobacillus rhamnosus Lc 705 Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 101100194706 Mus musculus Arhgap32 gene Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 101100194707 Xenopus laevis arhgap32 gene Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940124572 antihypotensive agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229940097633 capoten Drugs 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000018459 dissociative disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000015244 frankfurter Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000014659 low sodium diet Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 235000020122 reconstituted milk Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000011497 sour milk drink Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Water Supply & Treatment (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (45)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI992360A FI113741B (fi) | 1999-11-01 | 1999-11-01 | Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi |
| AT00972940T ATE285470T1 (de) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus, welches blutdrucksenkende di- und tripeptide herstellt |
| PCT/FI2000/000942 WO2001032905A1 (en) | 1999-11-01 | 2000-10-30 | Process for producing a product containing antihypertensive tripeptides |
| HR20020378A HRP20020378B1 (en) | 1999-11-01 | 2000-10-30 | Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| RU2002114327/13A RU2270855C2 (ru) | 1999-11-01 | 2000-10-30 | Штамм бактерий lactobacillus helveticus lbk-16 h, используемый для получения пробиотика, бактериальный пробиотический препарат и пищевой продукт |
| DK00972941T DK1226267T3 (da) | 1999-11-01 | 2000-10-30 | Fremgangsmåde til fremstilling af et produkt, der indeholder antihypertensive tripeptider |
| KR1020027005619A KR100704441B1 (ko) | 1999-11-01 | 2000-10-30 | 항고혈압성 디펩타이드 및 트리펩타이드를 생산하는락토바실러스 헬베티쿠스 |
| DK00972940T DK1226230T3 (da) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus, der producerer antihypertensive di- og tripeptider |
| HR20020377A HRP20020377B1 (en) | 1999-11-01 | 2000-10-30 | Process for producing a product containing antihypertensive tripeptides |
| EEP200200230A EE05461B1 (et) | 1999-11-01 | 2000-10-30 | Antihpertensiivseid tripeptiide sisaldava toote valmistamise meetod |
| PT00972941T PT1226267E (pt) | 1999-11-01 | 2000-10-30 | Processo para produzir um produto tripeptidos anti-hipertensores |
| CA002388354A CA2388354A1 (en) | 1999-11-01 | 2000-10-30 | Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| EP00972941A EP1226267B1 (en) | 1999-11-01 | 2000-10-30 | Process for producing a product containing antihypertensive tripeptides |
| CNB008153353A CN1164761C (zh) | 1999-11-01 | 2000-10-30 | 生产含抗高血压三肽产品的方法 |
| RU2002114359/13A RU2276689C2 (ru) | 1999-11-01 | 2000-10-30 | Способ получения продукта, содержащего гипотензивные пептиды, продукт, полученный способом, и пищевой продукт |
| NZ518470A NZ518470A (en) | 1999-11-01 | 2000-10-30 | Process for producing a product containing antihypertensive peptides and the product formed by this process |
| PT00972940T PT1226230E (pt) | 1999-11-01 | 2000-10-30 | Lactobacillus helvetius produtor de di e tripeptidos antihipertensores |
| DE60016959T DE60016959T2 (de) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus, welches blutdrucksenkende di- und tripeptide herstellt |
| NZ518493A NZ518493A (en) | 1999-11-01 | 2000-10-30 | Lactobacillus helvetius producing antihypertensive DI- and tripeptides |
| DE60010742T DE60010742T2 (de) | 1999-11-01 | 2000-10-30 | Verfahren zur herstellung eines produktes, welches gegen bluthochdruck gerichtete tripeptide enthält |
| PL00364790A PL364790A1 (pl) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus wytwarzający dwu-i trójpeptydy przeciw nadciśnieniu |
| AT00972941T ATE266735T1 (de) | 1999-11-01 | 2000-10-30 | Verfahren zur herstellung eines produktes, welches gegen bluthochdruck gerichtete tripeptide enthält |
| JP2001535586A JP4172681B2 (ja) | 1999-11-01 | 2000-10-30 | 抗高血圧性トリペプチドを含有する産物をつくる方法 |
| KR1020027005618A KR100718709B1 (ko) | 1999-11-01 | 2000-10-30 | 항고혈압 트리펩타이드를 함유하는 제품의 생산 방법 |
| EEP200200231A EE200200231A (xx) | 1999-11-01 | 2000-10-30 | Antih�pertensiivseid di- ja tripeptiide produtseeriv Lactobacillus helveticus |
| PL355670A PL204119B1 (pl) | 1999-11-01 | 2000-10-30 | Sposób wytwarzania produktu zawierającego trójpeptydy przeciw nadciśnieniu, produkt zawierający te trójpeptydy, produkt zawierający te trójpeptydy do zastosowania jako czynnik przeciw nadciścnieniu, produkt do zastosowania w wytwarzaniu substancji jadalnych, produkt do zastosowania w przemyśle i produkt jadalny |
| AU11498/01A AU777795B2 (en) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| AU11499/01A AU769432B2 (en) | 1999-11-01 | 2000-10-30 | Process for producing a product containing antihypertensive tripeptides |
| HU0203185A HUP0203185A3 (en) | 1999-11-01 | 2000-10-30 | Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| JP2001535518A JP3695648B2 (ja) | 1999-11-01 | 2000-10-30 | 抗高血圧性ジペプチドおよびトリペプチドを産生するＬａｃｔｏｂａｃｉｌｌｕｓ ｈｅｌｖｅｔｉｃｕｓ |
| PCT/FI2000/000941 WO2001032836A1 (en) | 1999-11-01 | 2000-10-30 | Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| EP00972940A EP1226230B1 (en) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| CNB008153930A CN1197956C (zh) | 1999-11-01 | 2000-10-30 | 产生抗高血压二和三肽的瑞士乳杆菌 |
| CZ20021431A CZ302271B6 (cs) | 1999-11-01 | 2000-10-30 | Zpusob výroby produktu obsahujícího antihypertenzivní tripeptidy |
| CA002387738A CA2387738C (en) | 1999-11-01 | 2000-10-30 | Process for producing a product containing antihypertensive tripeptides |
| US10/111,914 US6890529B1 (en) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| ES00972941T ES2220557T3 (es) | 1999-11-01 | 2000-10-30 | Procedimiento de fabricacion de un producto que contiene tripeptidos antihipertensores. |
| US10/111,942 US6972282B1 (en) | 1999-11-01 | 2000-10-30 | Process for producing a product containing antihypertensive tripeptides |
| CZ20021369A CZ294146B6 (cs) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus LBK@�@ H a jeho použitíŹ bakteriální preparát a jedlý produkt |
| ES00972940T ES2234686T3 (es) | 1999-11-01 | 2000-10-30 | Lactobacillus helveticus que produce dipeptidos y tripeptidos antihipertensivos. |
| HU0203256A HU226200B1 (en) | 1999-11-01 | 2000-10-30 | Process for producing a product containing antihypertensive tripeptides |
| ZA200203179A ZA200203179B (en) | 1999-11-01 | 2002-04-22 | Process for producing a product containing antihypertensive tripeptides. |
| ZA200203172A ZA200203172B (en) | 1999-11-01 | 2002-04-22 | Lactobacillus helveticus producing antihypertensive di- and tripeptides. |
| NO20022062A NO20022062L (no) | 1999-11-01 | 2002-04-30 | Lactobacillus helveticus som produserer antihypertensive di- og tripeptider |
| NO20022061A NO330951B1 (no) | 1999-11-01 | 2002-04-30 | Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI992360 | 1999-11-01 | ||
| FI992360A FI113741B (fi) | 1999-11-01 | 1999-11-01 | Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI19992360L FI19992360L (fi) | 2001-05-02 |
| FI113741B true FI113741B (fi) | 2004-06-15 |
Family
ID=8555541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI992360A FI113741B (fi) | 1999-11-01 | 1999-11-01 | Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6890529B1 (cs) |
| EP (2) | EP1226230B1 (cs) |
| JP (2) | JP4172681B2 (cs) |
| KR (2) | KR100704441B1 (cs) |
| CN (2) | CN1164761C (cs) |
| AT (2) | ATE285470T1 (cs) |
| AU (2) | AU777795B2 (cs) |
| CA (2) | CA2388354A1 (cs) |
| CZ (2) | CZ294146B6 (cs) |
| DE (2) | DE60010742T2 (cs) |
| DK (2) | DK1226230T3 (cs) |
| EE (2) | EE05461B1 (cs) |
| ES (2) | ES2220557T3 (cs) |
| FI (1) | FI113741B (cs) |
| HR (2) | HRP20020378B1 (cs) |
| HU (2) | HUP0203185A3 (cs) |
| NO (2) | NO20022062L (cs) |
| NZ (2) | NZ518470A (cs) |
| PL (2) | PL364790A1 (cs) |
| PT (2) | PT1226267E (cs) |
| RU (2) | RU2270855C2 (cs) |
| WO (2) | WO2001032836A1 (cs) |
| ZA (2) | ZA200203172B (cs) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI113741B (fi) * | 1999-11-01 | 2004-06-15 | Valio Oy | Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi |
| FI112031B (fi) | 2002-02-25 | 2003-10-31 | Valio Oy | Biologisesti aktiivisen tuotteen uusi käyttö |
| AU2003236689A1 (en) | 2002-06-04 | 2003-12-19 | Dsm Ip Assets B.V. | Protein hydrolysate rich in tripeptides |
| EP1529114A1 (en) * | 2002-08-09 | 2005-05-11 | Chr. Hansen A/S | Process for preparing peptides with anti-hypertensive properties |
| CA2509627A1 (en) * | 2003-01-06 | 2004-07-22 | Unilever Plc | Fermented milk product comprising tripeptide vpp and/or ipp |
| TWI328457B (en) * | 2003-03-18 | 2010-08-11 | Suntory Holdings Ltd | Angiotensin-converting enzyme inhibitory peptides |
| US7718171B2 (en) | 2003-04-07 | 2010-05-18 | Chr. Hansen A/S | Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus |
| BRPI0409536A (pt) | 2003-05-05 | 2006-04-18 | Unilever Nv | processo para a preparação de um produto de caseìna hidrolisada, produtos de caseìna hidrolisada e produtos alimentìcios |
| EP1727440A1 (en) * | 2004-03-19 | 2006-12-06 | Campina Nederland Holding B.V. | Method of preparing a food ingredient and food product having angiotensin-i-converting enzyme inhibiting properties and products thus obtained |
| CN101039685B (zh) | 2004-03-31 | 2010-06-16 | 卡尔皮斯株式会社 | 预防、抑制肝病的制剂和预防、抑制肝病的功能食品 |
| US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
| JP4723501B2 (ja) * | 2004-07-05 | 2011-07-13 | カルピス株式会社 | ペプチド混合物の製造法、抗高血圧ペプチド含有発酵乳の製造法及び抗高血圧ペプチド製剤の製造法 |
| EA011865B1 (ru) * | 2004-07-12 | 2009-06-30 | ДСМ Ай Пи ЭССЕТС Б.В. | Протеиновые гидролизаты, снижающие давление крови |
| EP1685764A1 (en) | 2005-01-27 | 2006-08-02 | Globus Egg Sciences B.V. | Anti-hypertensive functional food products |
| BRPI0514903A (pt) | 2004-09-03 | 2008-06-24 | Hansens Lab | proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos |
| FR2876876B1 (fr) * | 2004-10-22 | 2007-02-16 | Gervais Danone Sa | Protection d'ingredients alimentaires bioactifs par l'utilisation de microorganismes presentant une capacite de metabolisation reduite |
| FR2876874B1 (fr) * | 2004-10-22 | 2007-02-16 | Gervais Danone Sa | Protection d'ingredients alimentaires bioactifs par l'utilisation d'ingredients leurres |
| DK1827477T3 (en) * | 2004-12-22 | 2015-11-09 | Dsm Ip Assets Bv | Antihypertensive Oligopeptides IN A SINGLE STEP ENZYMATIC |
| WO2006084560A1 (en) * | 2005-02-09 | 2006-08-17 | Unilever N.V. | Composition comprising peptide |
| US8088597B2 (en) * | 2005-02-24 | 2012-01-03 | Dsm Ip Assets B.V. | Blood pressure lowering peptides from glycomacropeptide |
| US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
| EP2439266B1 (en) * | 2005-11-28 | 2017-02-01 | DSM IP Assets B.V. | Enzyme preparations yielding a clean taste |
| KR20080095898A (ko) | 2006-02-14 | 2008-10-29 | 칼피스가부시키가이샤 | 혈관확장제 |
| TWI418359B (zh) | 2006-02-14 | 2013-12-11 | Calpis Co Ltd | 動脈硬化預防劑，血管內膜增厚抑制劑，血管內皮功能改善劑及功能性食品 |
| DE602006004956D1 (de) * | 2006-02-20 | 2009-03-12 | Gervais Danone Sa | Neue Stämme von Lactobacillus helveticus |
| EP1820850B1 (fr) * | 2006-02-20 | 2009-02-25 | Compagnie Gervais Danone | Nouvelles souches de lactobacillus helveticus |
| EP1820851B9 (fr) * | 2006-02-20 | 2012-06-27 | Compagnie Gervais Danone | Souches de Lactobacillus helveticus ne fermentant pas le lactose |
| CN100370019C (zh) * | 2006-04-21 | 2008-02-20 | 江南大学 | 一种具有抗高血压作用的植物乳杆菌cw006 |
| RU2457852C2 (ru) * | 2006-05-15 | 2012-08-10 | Валио Лтд | Новое применение терапевтически эффективных пептидов |
| US20090111758A1 (en) * | 2006-05-15 | 2009-04-30 | Valio Ltd. | Use of therapeutically useful peptides |
| NZ597178A (en) * | 2006-09-04 | 2012-08-31 | Megmilk Snow Brand Co Ltd | Agent comprising Lactobacillus helveticus for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
| PT1915913E (pt) * | 2006-10-23 | 2016-02-16 | Nestec Sa | Modulação do sabor e do aroma de produtos lácteos por biotransformação |
| EP1952703B1 (de) * | 2007-02-02 | 2010-08-25 | May, Amadeus Alexander | Produkt mit lebenden probiotischen Mikroorganismen |
| US10842813B2 (en) | 2007-02-26 | 2020-11-24 | Heartbeet Ltd | Compositions of nitrates and methods of use thereof |
| US11759477B2 (en) | 2007-02-26 | 2023-09-19 | Heartbeet Ltd. | Compositions of nitrates and methods of use thereof |
| MX2009010428A (es) * | 2007-03-27 | 2009-12-01 | Calpis Co Ltd | Agente profilactico para insuficiencia renal. |
| BRPI0915107A2 (pt) * | 2008-06-12 | 2015-08-11 | Nestec Sa | Cepas de lactobacillus heveticus para produção de peptídeos hipotensivos |
| DE102008032828A1 (de) | 2008-07-02 | 2010-01-07 | Technische Universität Dresden | Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel |
| FI122531B (fi) * | 2009-09-30 | 2012-03-15 | Valio Oy | Juusto ja menetelmä sen valmistamiseksi |
| CN102786579B (zh) * | 2012-07-17 | 2014-07-09 | 上海交通大学 | 抗高血压活性肽vip |
| CN102786580A (zh) * | 2012-07-17 | 2012-11-21 | 上海交通大学 | 抗高血压活性肽ivp |
| RU2580052C1 (ru) * | 2014-12-24 | 2016-04-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | Штамм lactobacillus helveticus вкпм в-11176, полученный на доступных питательных средах |
| RU2577112C1 (ru) * | 2014-12-25 | 2016-03-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | Штамм lactobacillus helveticus вкпм в-11175, полученный на доступных питательных средах |
| BR112019010024B1 (pt) | 2016-12-02 | 2023-01-31 | Fairlife, Llc | Processos para a preparação de uma composição láctea seca, composição láctea seca, processo de reconstituição de um produto de leite e produto de leite reconstituído |
| RU2685912C1 (ru) * | 2018-03-14 | 2019-04-23 | Федеральное государственное автономное научное учреждение "Научно-исследовательский институт хлебопекарной промышленности" | Штамм бактерий lactobacillus amylolyticus, используемый для приготовления термофильной заквашенной заварки |
| RU2728171C2 (ru) * | 2018-11-08 | 2020-07-28 | Общество с ограниченной ответственностью "Инновационные биотехнологии" (ООО "Инбиотех") | Штамм бактерий Lactobacillus helveticus T-5068, используемый в качестве закваски прямого внесения для приготовления кисломолочных продуктов |
| CN109517763B (zh) * | 2018-12-27 | 2022-03-22 | 内蒙古农业大学 | 瑞士乳杆菌h11及其应用 |
| TWI713972B (zh) * | 2019-01-14 | 2020-12-21 | 大江生醫股份有限公司 | 改善呼吸道健康之益生菌株及其組合物與用途 |
| WO2021195718A1 (en) * | 2020-04-02 | 2021-10-07 | Ahtesh Fatah Bashir | Milk fermentation process |
| CN112029784A (zh) * | 2020-09-16 | 2020-12-04 | 内蒙古农业大学 | 一个与蛋白水解能力相关的基因及基于该基因的高蛋白水解能力瑞士乳杆菌的筛选方法 |
| KR102684805B1 (ko) | 2023-12-20 | 2024-07-12 | 푸른하늘환경주식회사 | 우수 유출수의 정화 처리 장치 |
| KR102687298B1 (ko) | 2023-12-20 | 2024-07-22 | 푸른하늘환경주식회사 | 비점오염물질 저감 및 우수 정화 장치 |
| CN117986337B (zh) * | 2024-02-02 | 2024-08-16 | 杭州御寿生物科技有限公司 | 一种提高免疫力的益生菌组合物以及在治疗疾病中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2483748A1 (fr) * | 1980-06-06 | 1981-12-11 | Corning Glass Works | Procede d'hydrolyse du lactose contenu dans les lactoserums a l'aide de lactase immobilisee |
| SU1264889A1 (ru) * | 1984-07-25 | 1986-10-23 | Киевский Ордена Трудового Красного Знамени Технологический Институт Пищевой Промышленности | Способ производства молочно-белкового продукта дл плавлени |
| JPS6153216A (ja) * | 1984-08-23 | 1986-03-17 | Rikagaku Kenkyusho | 高血圧症予防治療剤 |
| JP2782142B2 (ja) * | 1992-07-23 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害剤及びその製造法 |
| JP2782153B2 (ja) | 1992-11-09 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害ペプチドの製造法 |
| JP2824821B2 (ja) | 1993-11-04 | 1998-11-18 | カルピス株式会社 | 乳酸菌及び発酵乳製品 |
| GB2294191B (en) * | 1994-10-06 | 1997-10-01 | Waterford Creamery Ltd | Cheese manufacture |
| JP3782837B2 (ja) * | 1995-04-10 | 2006-06-07 | カルピス株式会社 | 血圧降下剤及びその製造法 |
| JPH09188694A (ja) | 1996-01-10 | 1997-07-22 | Otsuka Shokuhin Kk | ペプチド、アンジオテンシン変換酵素阻害組成物及びその製法 |
| JP3746556B2 (ja) | 1996-02-09 | 2006-02-15 | カルピス株式会社 | プラスミド及びプラスミドベクター |
| US5854029A (en) * | 1996-08-02 | 1998-12-29 | Calpis Co., Ltd. | Method for preparing antihypertensive agent |
| JP3028411B2 (ja) * | 1997-09-26 | 2000-04-04 | カルピス株式会社 | トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌 |
| JP4727770B2 (ja) * | 1997-09-26 | 2011-07-20 | カルピス株式会社 | 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤 |
| GB9720633D0 (en) * | 1997-09-29 | 1997-11-26 | Univ Bristol | BHV-2 vector |
| FI104783B (fi) | 1998-02-12 | 2000-04-14 | Valio Oy | Herasuolajauhe, menetelmä sen valmistamiseksi ja sen käyttö |
| FI113741B (fi) * | 1999-11-01 | 2004-06-15 | Valio Oy | Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi |
| US6514941B1 (en) * | 1999-12-10 | 2003-02-04 | Campina Melkunie B.V. | Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides |
-
1999
- 1999-11-01 FI FI992360A patent/FI113741B/fi not_active IP Right Cessation
-
2000
- 2000-10-30 DE DE60010742T patent/DE60010742T2/de not_active Expired - Lifetime
- 2000-10-30 RU RU2002114327/13A patent/RU2270855C2/ru active
- 2000-10-30 US US10/111,914 patent/US6890529B1/en not_active Expired - Fee Related
- 2000-10-30 AT AT00972940T patent/ATE285470T1/de not_active IP Right Cessation
- 2000-10-30 AU AU11498/01A patent/AU777795B2/en not_active Ceased
- 2000-10-30 HU HU0203185A patent/HUP0203185A3/hu unknown
- 2000-10-30 AU AU11499/01A patent/AU769432B2/en not_active Ceased
- 2000-10-30 US US10/111,942 patent/US6972282B1/en not_active Expired - Fee Related
- 2000-10-30 JP JP2001535586A patent/JP4172681B2/ja not_active Expired - Fee Related
- 2000-10-30 NZ NZ518470A patent/NZ518470A/xx unknown
- 2000-10-30 EE EEP200200230A patent/EE05461B1/xx not_active IP Right Cessation
- 2000-10-30 CN CNB008153353A patent/CN1164761C/zh not_active Expired - Fee Related
- 2000-10-30 KR KR1020027005619A patent/KR100704441B1/ko not_active Expired - Fee Related
- 2000-10-30 PL PL00364790A patent/PL364790A1/xx not_active IP Right Cessation
- 2000-10-30 RU RU2002114359/13A patent/RU2276689C2/ru not_active IP Right Cessation
- 2000-10-30 CZ CZ20021369A patent/CZ294146B6/cs not_active IP Right Cessation
- 2000-10-30 ES ES00972941T patent/ES2220557T3/es not_active Expired - Lifetime
- 2000-10-30 DK DK00972940T patent/DK1226230T3/da active
- 2000-10-30 EP EP00972940A patent/EP1226230B1/en not_active Expired - Lifetime
- 2000-10-30 DE DE60016959T patent/DE60016959T2/de not_active Expired - Fee Related
- 2000-10-30 CA CA002388354A patent/CA2388354A1/en not_active Abandoned
- 2000-10-30 CZ CZ20021431A patent/CZ302271B6/cs not_active IP Right Cessation
- 2000-10-30 CN CNB008153930A patent/CN1197956C/zh not_active Expired - Fee Related
- 2000-10-30 PT PT00972941T patent/PT1226267E/pt unknown
- 2000-10-30 PT PT00972940T patent/PT1226230E/pt unknown
- 2000-10-30 PL PL355670A patent/PL204119B1/pl not_active IP Right Cessation
- 2000-10-30 KR KR1020027005618A patent/KR100718709B1/ko not_active Expired - Fee Related
- 2000-10-30 NZ NZ518493A patent/NZ518493A/xx unknown
- 2000-10-30 WO PCT/FI2000/000941 patent/WO2001032836A1/en not_active Ceased
- 2000-10-30 HR HR20020378A patent/HRP20020378B1/xx not_active IP Right Cessation
- 2000-10-30 ES ES00972940T patent/ES2234686T3/es not_active Expired - Lifetime
- 2000-10-30 HR HR20020377A patent/HRP20020377B1/xx not_active IP Right Cessation
- 2000-10-30 EP EP00972941A patent/EP1226267B1/en not_active Expired - Lifetime
- 2000-10-30 WO PCT/FI2000/000942 patent/WO2001032905A1/en not_active Ceased
- 2000-10-30 EE EEP200200231A patent/EE200200231A/xx unknown
- 2000-10-30 AT AT00972941T patent/ATE266735T1/de active
- 2000-10-30 JP JP2001535518A patent/JP3695648B2/ja not_active Expired - Lifetime
- 2000-10-30 HU HU0203256A patent/HU226200B1/hu not_active IP Right Cessation
- 2000-10-30 DK DK00972941T patent/DK1226267T3/da active
- 2000-10-30 CA CA002387738A patent/CA2387738C/en not_active Expired - Fee Related
-
2002
- 2002-04-22 ZA ZA200203172A patent/ZA200203172B/xx unknown
- 2002-04-22 ZA ZA200203179A patent/ZA200203179B/xx unknown
- 2002-04-30 NO NO20022062A patent/NO20022062L/no not_active Application Discontinuation
- 2002-04-30 NO NO20022061A patent/NO330951B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI113741B (fi) | Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi | |
| Minervini et al. | Fermented goats’ milk produced with selected multiple starters as a potentially functional food | |
| Takano | Anti-hypertensive activity of fermented dairy products containing biogenic peptides | |
| JP5888701B2 (ja) | 高タンパク質分解活性を有するラクトバチルス・ヘルベティカス菌 | |
| JP2011504363A (ja) | 改良された生理活性ペプチドの生成 | |
| WO2005096847A1 (en) | Method of preparing a food ingredient and food product having angiotensin-i-converting enzyme inhibiting properties and products thus obtained | |
| MXPA05007267A (es) | Producto de leche fermentada que comprende tripeptidos val-pro-pro (vpp) e ile-pro-pro (ipp). | |
| FI112031B (fi) | Biologisesti aktiivisen tuotteen uusi käyttö | |
| FI120267B (fi) | Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi | |
| JP4268785B2 (ja) | カルシウム吸収促進及びリン酸カルシウム結晶成長促進剤 | |
| Acharya | Production of functional food, Fruit ravioli with antihypertensive peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |